Eligibility Ovarian Cancer NCT00181688

1 Formulários

StudyEvent: Eligibility
1. Eligibility Ovarian Cancer NCT00181688

Name

Tipo

Description | Question | Decode (Coded Value)

Tipo de dados

Alias

Inclusion Criteria

Item Group

C1512693 (UMLS CUI)

Ovarian Carcinoma Primary | Primary peritoneal carcinoma | Fallopian Tube Carcinoma Primary

Item

histologic or cytologic history diagnosis of primary ovarian, primary peritoneal or tubal carcinoma

boolean

C0029925 (UMLS CUI [1,1])
C0205225 (UMLS CUI [1,2])
C1514428 (UMLS CUI [2])
C0238122 (UMLS CUI [3,1])
C0205225 (UMLS CUI [3,2])

Ovarian Carcinoma Asymptomatic

Item

asymptomatic from ovarian cancer

boolean

C0029925 (UMLS CUI [1,1])
C0231221 (UMLS CUI [1,2])

Ovarian cancer recurrent Evidence of | Carcinoma of peritoneum Recurrent Evidence of | Recurrent Fallopian Tube Carcinoma Evidence of

Item

evidence of recurrent ovarian, peritoneal or tubal carcinoma

boolean

C0278689 (UMLS CUI [1,1])
C0332120 (UMLS CUI [1,2])
C0948303 (UMLS CUI [2,1])
C2945760 (UMLS CUI [2,2])
C0332120 (UMLS CUI [2,3])
C3897738 (UMLS CUI [3,1])
C0332120 (UMLS CUI [3,2])

Tumor tissue sample Estrogen receptor positive | Tumor tissue sample Progesterone receptor positive

Item

tumor sample must be positive for er and/or pr

boolean

C0475358 (UMLS CUI [1,1])
C0279754 (UMLS CUI [1,2])
C0475358 (UMLS CUI [2,1])
C0279759 (UMLS CUI [2,2])

Age

Item

18 years of age or older

boolean

C0001779 (UMLS CUI [1])

ECOG performance status

Item

ecog performance status of less than or equal to 1

boolean

C1520224 (UMLS CUI [1])

Intake Oral Ability

Item

must be able to tolerate oral intake

boolean

C1512806 (UMLS CUI [1,1])
C1527415 (UMLS CUI [1,2])
C0085732 (UMLS CUI [1,3])

Exclusion Criteria

Item Group

C0680251 (UMLS CUI)

Hypersensitivity Iressa | Hypersensitivity Iressa Excipient

Item

known hypersensitivity to iressa or any of the excipients of this product

boolean

C0020517 (UMLS CUI [1,1])
C0919281 (UMLS CUI [1,2])
C0020517 (UMLS CUI [2,1])
C0919281 (UMLS CUI [2,2])
C0015237 (UMLS CUI [2,3])

Malignant Neoplasms

Item

other coexisting malignancies or malignancies diagnosed within the last 5 years

boolean

C0006826 (UMLS CUI [1])

Item

concomitant use of phenytoin, carbamazepine, barbiturates, rifampicin, phenobarbital or st. john's wort

boolean

C0031507 (UMLS CUI [1])
C0006949 (UMLS CUI [2])
C0004745 (UMLS CUI [3])
C0035608 (UMLS CUI [4])
C0031412 (UMLS CUI [5])
C0813171 (UMLS CUI [6])

Drugs, Non-Prescription | Investigational New Drugs

Item

treatment with a non-approved or investigational drug within 30 days

boolean

C0013231 (UMLS CUI [1])
C0013230 (UMLS CUI [2])

Toxicity chronic Unresolved Due to cancer treatment | CTCAE Grades | Alopecia

Item

any unresolved chronic toxicity greater than ctc grad 2 from previous anticancer therapy (except alopecia)

boolean

C0600688 (UMLS CUI [1,1])
C0205191 (UMLS CUI [1,2])
C0443342 (UMLS CUI [1,3])
C0678226 (UMLS CUI [1,4])
C0920425 (UMLS CUI [1,5])
C1516728 (UMLS CUI [2])
C0002170 (UMLS CUI [3])

cancer surgery | major surgery | Therapeutic procedure Incomplete

Item

incomplete healing from previous oncologic or other major surgery

boolean

C0920424 (UMLS CUI [1])
C0679637 (UMLS CUI [2])
C0087111 (UMLS CUI [3,1])
C0205257 (UMLS CUI [3,2])

Creatinine measurement, serum | CTCAE Grades

Item

serum creatinine level greater than ctc grade 2

boolean

C0201976 (UMLS CUI [1])
C1516728 (UMLS CUI [2])

Pregnancy | Breast Feeding

Item

pregnant or breast feeding

boolean

C0032961 (UMLS CUI [1])
C0006147 (UMLS CUI [2])

Systemic disease Uncontrolled Severe

Item

severe uncontrolled systemic disease

boolean

C0442893 (UMLS CUI [1,1])
C0205318 (UMLS CUI [1,2])
C0205082 (UMLS CUI [1,3])

Disease Significant At risk Study Subject Participation Status | Laboratory finding At risk Study Subject Participation Status

Item

significant clinical disorder or laboratory finding that makes it potentially unsafe for the subject to participate

boolean

C0012634 (UMLS CUI [1,1])
C0750502 (UMLS CUI [1,2])
C1444641 (UMLS CUI [1,3])
C2348568 (UMLS CUI [1,4])
C0587081 (UMLS CUI [2,1])
C1444641 (UMLS CUI [2,2])
C2348568 (UMLS CUI [2,3])

Antineoplastic Agents Investigational | Systemic Chemotherapy | Therapeutic radiology procedure

Item

patients currently receiving other investigational antineoplastic agents, on systemic chemotherapy or under radiation therapy treatment

boolean

C0003392 (UMLS CUI [1,1])
C1517586 (UMLS CUI [1,2])
C1883256 (UMLS CUI [2])
C1522449 (UMLS CUI [3])

anastrozole | Aromatase Inhibitors

Item

patients previously treated with anastrozole or other aromatase inhibitor

boolean

C0290883 (UMLS CUI [1])
C0593802 (UMLS CUI [2])

Oral medication Receive Unable

Item

unable to tolerate oral medications

boolean

C0175795 (UMLS CUI [1,1])
C1514756 (UMLS CUI [1,2])
C1299582 (UMLS CUI [1,3])

Intestinal Obstruction Evidence Clinical | Intestinal Obstruction Impending Evidence Clinical | Intestinal Obstruction Evidence roentgenographic | Intestinal Obstruction Impending Evidence roentgenographic

Item

clinical and/or radiographic evidence of current or impending bowel obstruction

boolean

C0021843 (UMLS CUI [1,1])
C3887511 (UMLS CUI [1,2])
C0205210 (UMLS CUI [1,3])
C0021843 (UMLS CUI [2,1])
C0332190 (UMLS CUI [2,2])
C3887511 (UMLS CUI [2,3])
C0205210 (UMLS CUI [2,4])
C0021843 (UMLS CUI [3,1])
C3887511 (UMLS CUI [3,2])
C0034571 (UMLS CUI [3,3])
C0021843 (UMLS CUI [4,1])
C0332190 (UMLS CUI [4,2])
C3887511 (UMLS CUI [4,3])
C0034571 (UMLS CUI [4,4])

Voltar ao início da página

ID

Descrição

Link

Palavras-chave

Versões (1)

Transferido a

DOI

Licença

Comentários do modelo :

Comentários do grupo de itens para :

Comentários do item para :

Eligibility Ovarian Cancer NCT00181688